Logo image of BVXV

BIONDVAX PHARMACEUTICALS-ADR (BVXV) Stock Income Statement

USA - NASDAQ:BVXV - US09073Q2049 - ADR

1.36 USD
+0.05 (+3.82%)
Last: 9/6/2023, 8:00:01 PM
1.38 USD
+0.02 (+1.47%)
After Hours: 9/6/2023, 8:00:01 PM

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
BVXV Revenue ChartBVXV Revenue over time chart
00000
Gross Premiums Earned
BVXV Gross Premiums Earned ChartBVXV Gross Premiums Earned over time chart
nullnullnullnullnull
Loss Claims
BVXV Loss Claims ChartBVXV Loss Claims over time chart
nullnullnullnullnull
Deferred Policy Acquisition Expense
BVXV Deferred Policy Acquisition Expense ChartBVXV Deferred Policy Acquisition Expense over time chart
nullnullnullnullnull
Net Interest Income
BVXV Net Interest Income ChartBVXV Net Interest Income over time chart
nullnullnullnullnull
Non Interest Income
BVXV Non Interest Income ChartBVXV Non Interest Income over time chart
nullnullnullnullnull
Loan Loss Provision
BVXV Loan Loss Provision ChartBVXV Loan Loss Provision over time chart
nullnullnullnullnull
Net Interest Income after Provision
BVXV Net Interest Income after Provision ChartBVXV Net Interest Income after Provision over time chart
nullnullnullnullnull
Non Interest Expense
BVXV Non Interest Expense ChartBVXV Non Interest Expense over time chart
nullnullnullnullnull
Minority Interest Expense
BVXV Minority Interest Expense ChartBVXV Minority Interest Expense over time chart
nullnullnullnullnull
Cost Of Goods
BVXV Cost Of Goods ChartBVXV Cost Of Goods over time chart
nullnullnullnullnull
Gross Profit
BVXV Gross Profit ChartBVXV Gross Profit over time chart
nullnullnullnullnull
Operating Expenses
BVXV Operating Expenses ChartBVXV Operating Expenses over time chart
9.52M-7.33M78.35M77.07M23.66M
Research and Development
BVXV Research and Development ChartBVXV Research and Development over time chart
2.32M49.58M67.35M71.72M18.47M
Selling, General, and Administrative Expenses
BVXV Selling, General, and Administrative Expenses ChartBVXV Selling, General, and Administrative Expenses over time chart
6.55M16.14M9.35M5.09M4.75M
Operating Income
BVXV Operating Income ChartBVXV Operating Income over time chart
-9.52M7.33M-78.35M-77.07M-23.66M
Interest Income/Expense
BVXV Interest Income/Expense ChartBVXV Interest Income/Expense over time chart
-1.41M-11.79M-30.84M-10.66M-10.90M
Other Income/Expense
BVXV Other Income/Expense ChartBVXV Other Income/Expense over time chart
nullnullnullnullnull
Non Recurring Items
BVXV Non Recurring Items ChartBVXV Non Recurring Items over time chart
nullnullnullnullnull
Income Before Taxes
BVXV Income Before Taxes ChartBVXV Income Before Taxes over time chart
-10.92M-4.46M-109.19M-87.73M-34.55M
Income Tax
BVXV Income Tax ChartBVXV Income Tax over time chart
nullnullnullnullnull
Net Income
BVXV Net Income ChartBVXV Net Income over time chart
-10.92M-4.46M-109.19M-87.73M-34.55M
EBITDA
BVXV EBITDA ChartBVXV EBITDA over time chart
-8.88M9.77M-76.70M-76.81M-23.22M
 
Per Share Data
EPS Diluted Total Ops
BVXV EPS Diluted Total Ops ChartBVXV EPS Diluted Total Ops over time chart
-6.862352391029328-3.5468019387168326-117.04446397765547-120.59126591637231-60.295632958186154
Non GAAP EPS
BVXV Non GAAP EPS ChartBVXV Non GAAP EPS over time chart
null-1.259nullnullnull
 
Statistics

All data in USD

Charts

BVXV Income Statement data chartBVXV Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M -60M -80M -100M
BVXV Earnings Per Share (EPS) chartBVXV EPS Diluted and non-GAAP ChartEarnings Per Share 2015 2016 2017 2018 2019 2020 2021 -20 -40 -60 -80 -100